Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ARHGAP24 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DOCK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADCYAP1R1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
LOC286059 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
GPR183 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PHF11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FABP7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DMTN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CYP3A4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARHGEF39 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FNDC9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TPRXL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SARDH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ASTN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on